Local manufacturers of antibody based rapid testing kits (RTKs) for the coronavirus disease (Covid-19), whose kits were validated by the Indian Council of Medical Research (ICMR) and approved by the Central Drugs Standard Organisation (CDSCO), seem to be grappling with a sense of uncertainty as they are yet to receive any orders from the ICMR. […]
from LinkeWire https://ift.tt/3bR8Hq8
from LinkeWire https://ift.tt/3bR8Hq8
Comments
Post a Comment